Active ingredientDolasetronCat. No. P-D165-001CAS 115956-12-2Family · Pharmaceutical analytical standards
Dolasetron
An antiemetic that blocks serotonin 5-HT3 receptors, patented in 1986, used to prevent nausea and vomiting after chemotherapy, radiotherapy and surgery. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It is not used only in humans: in veterinary medicine it is sometimes given as an anti-vomiting drug to dogs and cats.
Go to the active ingredient →Active ingredientDolasetronCat. No. P-D165-001CAS 115956-12-2
Isotopically labelledDolasetron-d4Cat. No. P-D165-004
Isotopically labelledIndole-4,5,6,7-d4Cat. No. P-D165-005CAS 73509-22-5
ImpurityDolasetron isomerCat. No. P-D165-008
ImpurityDolasetron Impurity 1Cat. No. P-D165-009CAS 115956-03-1
ImpurityHydrodolasetronCat. No. P-D165-010CAS 127951-99-9No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.